Patient Education: Esophageal Varices (Beyond The Basics ~ NewTimes Blog

Medications to reduce pressure in the portal vein. A type of blood pressure drug called a beta blocker may help reduce blood pressure in your portal vein, decreasing the likelihood of bleeding. These medications include propranolol (Inderal, Innopran XL) and nadolol (Corgard). Using elastic bands to tie off bleeding veins.Portal hypertension and its consequence of bleeding varices are usually seen in people with moderately advanced liver disease. There may be other features such as ascities (fluid in the stomach) and encephalopathy (disturbance of brain function as a result of disordered liver function).A client with cirrhosis has portal hypertension, which is causing esophageal varices. What is the goal of the interventions that the nurse will provide? a) Cure the cirrhosis. b) Treat the esophageal varices. c) Reduce fluid accumulation and venous pressure. d) Promote optimal neurologic function.Which medication is used to decrease portal pressure, halting bleeding of esophageal varices? A patient with bleeding esophageal varices has had pharmacologic therapy with Octreotide (Sandostatin) and endoscopic therapy with esophageal varices banding, but the patient has continued to have bleeding. A patient is prescribed SandostatinEsophageal varices are caused by high blood pressure in blood vessels in and around the liver (portal hypertension). Esophageal varices usually cause no symptoms but can bleed spontaneously. Bleeding can be very severe and cause shock or rarely death.

Portal Hypertension - British Liver Trust

The regular follow-ups are required to check for recurrent bleeding and appropriate treatment is given to prevent more esophageal varices from developing. Treatment at the initial stage isSandostatin is preferred because of fewer side effects. Octreotide reduces pressure in the portal venous system and is preferred to the previously used agents, vasopressin (Pitressin) or terlipressin. Vitamin K promotes blood coagulation in bleeding conditions, resulting from liver disease.CONCLUSION: Esophageal varices banding, rather than portal pressure decrease, seems to be the main responsible factor for good results after combination of two therapies (surgery and endoscopy) for patients with portal hypertension due to schistosomiasis; further studies are necessary to confirm this hypothesis.Pharmacologic therapy for portal hypertension includes the use of beta-blockers, most commonly propranolol and nadolol. Brazilian investigators have suggested that the use of some statins (eg,...

Ch. 49 - PrepU Adaptive Learning Flashcards | Quizlet

Esophageal varices are enlarged veins that occur in the walls of the esophagus. The esophagus is the tube that connects your throat to your stomach. The pressure in the swollen veins is higher than normal. The increased pressure can cause sudden and severe bleeding. Because of this risk of bleeding, esophageal varices are a serious, possiblyPortal hypertension is the main abnormal mechanism that occurs in cirrhosis and the main cause of decompensation (e.g., ascites, GI bleeding) Non-selective beta-blockers (NSBBs) such as propranolol and nadolol* will reduce portal pressure The use of NSBBs lowers the risk of first variceal bleed and also prevents recurrent variceal hemorrhageIn patients with cirrhosis and variceal bleeding, the use of terlipressin reduces the portal vein pressure and decreases the pressure in esophageal varices. This can save lives when skilled endoscopists are not immediately available.Hepatic encephalopathy Which medication is used to decrease portal pressure, halting bleeding of esophageal varices? Vasopressin A client is admitted for suspected GI disease. Assessment data reveal muscle wasting, a decrease in chest and axillary hair, and increased bleeding tendency.Hamamelis, Chelidonium, and Cardus Marianus are the top homeopathic remedies used to treat esophageal varices. Homeopathic medicines for esophageal varices.

Hou W, Sanyal AJ. Ascites: prognosis and control. Med Clin North Am. 2009 Jul. 93(4):801-17, vii. [Medline].

Khurana I. Essentials of Medical Physiology. Noida, Uttar Pradesh, India: Elsevier; 2008. 215.

Lubel JS, Angus PW. Modern management of portal high blood pressure. Intern Med J. 2005 Jan. 35(1):45-9. [Medline].

Obara K. Hemodynamic mechanism of esophageal varices. Dig Endosc. 2006 Jan. 18(1):6-9.

Ravindra KV, Eng M, Marvin M. Current management of sinusoidal portal hypertension. Am Surg. 2008 Jan. 74(1):4-10. [Medline].

Theodorakis NG, Wang YN, Wu JM, Maluccio MA, Sitzmann JV, Skill NJ. Role of endothelial nitric oxide synthase within the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis fashion. Am J Physiol Gastrointest Liver Physiol. 2009 Oct. 297(4):G792-9. [Medline].

Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and reduced production of nitric oxide within the intrahepatic microcirculation of cirrhotic rats. Hepatology. 1998 Oct. 28(4):926-31. [Medline].

[Guideline] Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD, and the Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Prevention and control of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007 Sep. 102(9):2086-102. [Medline].

Bhathal PS, Grossman HJ. Reduction of the larger portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol. 1985. 1(4):325-37. [Medline].

Chawla Y, Duseja A, Dhiman RK. Review article: the trendy management of portal vein thrombosis. Aliment Pharmacol Ther. 2009 Nov 1. 30(9):881-94. [Medline].

Seijo S, Reverter E, Miquel R, et al. Role of hepatic vein catheterisation and brief elastography in the prognosis of idiopathic portal high blood pressure. Dig Liver Dis. 2012 Oct. 44(10):855-60. [Medline].

[Guideline] Dite P, Labrecque D, Fried M, et al, for the World Gastroenterology Organisation (WGO). World Gastroenterology Organisation apply guiding principle: esophageal varices. Munich, Germany: World Gastroenterology Organisation; 2008. Available at http://guideline.gov/content.aspx?id=13000. Accessed: August 6, 2012.

Thalheimer U, Leandro G, Samonakis DN, Triantos CK, Patch D, Burroughs AK. Assessment of the agreement between wedge hepatic vein force and portal vein drive in cirrhotic patients. Dig Liver Dis. 2005 Aug. 37(8):601-8. [Medline].

Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal high blood pressure and its complications. Gastroenterology. 2008 May. 134(6):1715-28. [Medline].

[Guideline] Qureshi W, Adler DG, Davila R, et al, for the Standards of Practice Committee. ASGE Guideline: the role of endoscopy in the control of variceal hemorrhage, updated July 2005. Gastrointest Endosc. 2005 Nov. 62(5):651-5. [Medline].

Heil T, Mattes P, Loeprecht H. Gastro-oesophageal reflux: an aetiological component for bleeding in oesophageal varices?. Br J Surg. 1980 Jul. 67(7):467-8. [Medline].

Eckardt VF, Grace ND. Gastroesophageal reflux and bleeding esophageal varices. Gastroenterology. 1979 Jan. 76(1):39-42. [Medline].

Yoon Y, Yi H. Surveillance report no. 88: liver cirrhosis mortality within the United States, 1970-2007. National Institute on Alcohol Abuse and Alcoholism. Available at http://pubs.niaaa.nih.gov/publications/surveillance88/Cirr07.htm. Accessed: Jul 17 2012.

Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul. 36(1):227-42. [Medline].

D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein drive gradient aid and prevention of variceal bleeding in cirrhosis: a systematic evaluation. Gastroenterology. 2006 Nov. 131(5):1611-24. [Medline].

Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ. Intrapulmonary vascular dilatations are commonplace in portopulmonary hypertension and could also be associated with reduced survival. Liver Transpl. 2015 Nov. 21(11):1355-64. [Medline].

Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding within the affected person with continual liver disease. Med Clin North Am. 1996 Sep. 80(5):1035-68. [Medline].

Boonpongmanee S, Fleischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as a reason of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004 Jun. 59(7):788-94. [Medline].

Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008 Mar. 67(3):422-9. [Medline].

Singal AK, Ahmad M, Soloway RD. Duplex Doppler ultrasound exam of the portal venous device: an emerging novel method for the estimation of portal vein drive. Dig Dis Sci. 2010 May. 55(5):1230-40. [Medline].

Wereszczynka-Siemiatkowska U, Swidnicka-Siergiejko A, Siemiatkowski A, et al. Endothelin 1 and transforming expansion factor-β1 correlate with liver function and portal drive in cirrhotic patients. Cytokine. 2015 Dec. 76(2):144-51. [Medline].

Beppu K, Inokuchi Ok, Koyanagi N, et al. Prediction of variceal hemorrhage through esophageal endoscopy. Gastrointest Endosc. 1981 Nov. 27(4):213-8. [Medline].

Khan NM, Shapiro AB. The white nipple signal: please do not disturb. Case Rep Gastroenterol. 2011 May. 5(2):386-90. [Medline]. [Full Text].

de Franchis R, Baveno VI Faculty. Expanding consensus in portal high blood pressure: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing handle portal hypertension. J Hepatol. 2015 Sep. 63(3):743-52. [Medline].

Castera L, Pinzani M, Bosch J. Non invasive analysis of portal high blood pressure the use of brief elastography. J Hepatol. 2012 Mar. 56(3):696-703. [Medline].

Kim TY, Jeong WK, Sohn JH, Kim J, Kim MY, Kim Y. Evaluation of portal hypertension by means of real-time shear wave elastography in cirrhotic patients. Liver Int. 2015 Nov. 35(11):2416-24. [Medline].

Salzl P, Reiberger T, Ferlitsch M, et al. Evaluation of portal high blood pressure and varices via acoustic radiation pressure impulse imaging of the liver when compared to brief elastography and AST to platelet ratio index. Ultraschall Med. 2014 Dec. 35(6):528-33. [Medline].

Elkrief L, Rautou PE, Ronot M, et al. Prospective comparability of spleen and liver stiffness by the use of shear-wave and brief elastography for detection of portal hypertension in cirrhosis. Radiology. 2015 May. 275(2):589-98. [Medline].

Pollo-Flores P, Soldan M, Santos UC, et al. Three months of simvastatin therapy vs. placebo for critical portal high blood pressure in cirrhosis: A randomized managed trial. Dig Liver Dis. 2015 Nov. 47(11):957-63. [Medline].

de Franchis R. Updating consensus in portal hypertension: document of the Baveno III Consensus Workshop on definitions, technique and healing methods in portal hypertension. J Hepatol. 2000 Nov. 33(5):846-52. [Medline].

Ferreira FG, Ribeiro MA, de Fatima Santos M, Assef JC, Szutan LA. Doppler ultrasound may just are expecting varices development and rebleeding after portal high blood pressure surgical procedure: courses from 146 EGDS and 10 years of follow-up. World J Surg. 2009 Oct. 33(10):2136-43. [Medline].

Burger-Klepp U, Karatosic R, Thum M, et al. Transesophageal echocardiography all over orthotopic liver transplantation in patients with esophagoastric varices. Transplantation. 2012 Jul 27. 94(2):192-6. [Medline].

Bonnet S, Sauvanet A, Bruno O, et al. Long-term survival after portal vein arterialization for portal vein thrombosis in orthotopic liver transplantation. Gastroenterol Clin Biol. 2010 Jan. 34(1):23-8. [Medline].

Lo GH, Lai KH, Cheng JS, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation by myself for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology. 2000 Sep. 32(3):461-5. [Medline].

Lo GH, Chen WC, Chan HH, et al. A randomized, controlled trial of banding ligation plus drug remedy versus drug therapy on my own in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol. 2009 Jun. 24(6):982-7. [Medline].

Kumar A, Jha SK, Sharma P, et al. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding occurrence. Gastroenterology. 2009 Sep. 137(3):892-901, 901.e1. [Medline].

de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on technique of prognosis and therapy in portal hypertension. J Hepatol. 2005 Jul. 43(1):167-76. [Medline].

Castaneda B, Morales J, Lionetti R, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001 Apr. 33(4):821-5. [Medline].

Sass DA, Chopra KB. Portal high blood pressure and variceal hemorrhage. Med Clin North Am. 2009 Jul. 93(4):837-53, vii-viii. [Medline].

Rimola A, Garcia-Tsao G, Navasa M. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus record. International Ascites Club. J Hepatol. 2000 Jan. 32(1):142-53. [Medline].

de Franchis R. Revising consensus in portal hypertension: file of the Baveno V consensus workshop on methodology of prognosis and treatment in portal high blood pressure. J Hepatol. 2010 Oct. 53(4):762-8. [Medline].

Chandramouli J, Jensen L. Vasopressin injection. [Updated October 16, 2012.] Alternative brokers & control. Table 1. Alternatives to vasopressin in selected scenarios. American Society of Health-System Pharmacists. Available at https://www.ashp.org/DrugShortages/Current/bulletin.aspx?id=795. Accessed: November 20, 2012.

Imperiale TF, Teran JC, McCullough AJ. A meta-analysis of somatostatin as opposed to vasopressin in the control of acute esophageal variceal hemorrhage. Gastroenterology. 1995 Oct. 109(4):1289-94. [Medline].

Baik SK, Jeong PH, Ji SW. Acute hemodynamic effects of octreotide and terlipressin in sufferers with cirrhosis: a randomized comparability. Am J Gastroenterol. 2005 Mar. 100(3):631-5. [Medline].

D'Amico G, Pagliaro L, Pietrosi G, Tarantino I. Emergency sclerotherapy versus vasoactive medication for bleeding oesophageal varices in cirrhotic sufferers. Cochrane Database Syst Rev. 2010 Mar 17. CD002233. [Medline].

Bajaj JS, Sanyal AJ. Treatment of lively variceal hemorrhage. UpToDate. Available at http://www.uptodate.com/contents/treatment-of-active-variceal-hemorrhage. Accessed: August 2, 2012.

Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov. 2(11):526-35. [Medline].

Avgerinos A, Armonis A, Stefanidis G, et al. Sustained upward push of portal pressure after sclerotherapy, but no longer band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004 Jun. 39(6):1623-30. [Medline].

Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AE, Jin B. Low occurrence of headaches from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol. 2010 Sep. 8(9):760-6. [Medline].

Garcia-Pagan JC, Caca Okay, Bureau C, Laleman W, Appenrodt B, Luca A. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010 Jun 24. 362(25):2370-9. [Medline].

Danziger J, Thummalakunta L, Nelson R, Faintuch S. The possibility of acute kidney injury with transjugular intrahepatic portosystemic shunts. J Nephrol. 2015 Dec. 28 (6):725-8. [Medline].

Samonakis DN, Triantos CK, Thalheimer U. Management of portal high blood pressure. Postgrad Med J. 2004 Nov. 80(949):634-41. [Medline].

D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal high blood pressure: an evidence-based manner. Semin Liver Dis. 1999. 19(4):475-505. [Medline].

Bosch J, Abraldes JG, Groszmann R. Current control of portal high blood pressure. J Hepatol. 2003. 38 Suppl 1:S54-68. [Medline].

Chang YW. Indication of remedy for esophageal varices: who and when?. Dig Endosc. 2006 Jan. 18(1):10-5.

Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and control of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep. 46(3):922-38. [Medline].

Sinagra E, Perricone G, D'Amico M, Tine F, D'Amico G. Systematic evaluate with meta-analysis: the haemodynamic results of carvedilol when compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther. 2014 Mar. 39(6):557-68. [Medline].

Chen S, Wang JJ, Wang QQ, et al. The effect of carvedilol and propranolol on portal high blood pressure in sufferers with cirrhosis: a meta-analysis. Patient Prefer Adherence. 2015. 9:961-70. [Medline]. [Full Text].

Li T, Ke W, Sun P, et al. Carvedilol for portal hypertension in cirrhosis: systematic overview with meta-analysis. BMJ Open. 2016 May 4. 6(5):e010902. [Medline]. [Full Text].

Merkel C, Marin R, Enzo E, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for number one prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto in line with L'ipertensione portale (GTIP). Lancet. 1996 Dec 21-28. 348(9043):1677-81. [Medline].

Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2000 May. 16(3):282-9. [Medline].

Gluud LL, Klingenberg S, Nikolova D, Gluud C. Banding ligation versus beta-blockers as number one prophylaxis in esophageal varices: systematic review of randomized trials. Am J Gastroenterol. 2007 Dec. 102(12):2842-8; quiz 2841, 2849. [Medline].

Lay CS, Tsai YT, Lee FY, et al. Endoscopic variceal ligation as opposed to propranolol in prophylaxis of first variceal bleeding in sufferers with cirrhosis. J Gastroenterol Hepatol. 2006 Feb. 21(2):413-9. [Medline].

Abraczinskas DR, Ookubo R, Grace ND. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime dedication?. Hepatology. 2001 Dec. 34(6):1096-102. [Medline].

Augustin S, Millan L, Gonzalez A, et al. Detection of early portal hypertension with regimen data and liver stiffness in sufferers with asymptomatic liver disease: a potential find out about. J Hepatol. 2014 Mar. 60(3):561-9. [Medline].

Bhasin DK, Siyad I. Variceal bleeding and portal high blood pressure: new lighting on old horizon. Endoscopy. 2004 Feb. 36(2):120-9. [Medline].

Boggs W. Simple strategy detects early portal hypertension in asymptomatic patients. Reuters Health Information. November 28, 2013. Available at http://www.medscape.com/viewarticle/815191. Accessed: December 10, 2013.

Chalasani N, Imperiale TF, Ismail A. Predictors of massive esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999 Nov. 94(11):3285-91. [Medline].

Conn HO. Portal hypertension, varices, and transjugular intrahepatic portosystemic shunts. Clin Liver Dis. 2000 Feb. 4(1):133-50, vii. [Medline].

de Franchis R, Primignani M. Why do varices bleed?. Gastroenterol Clin North Am. 1992 Mar. 21(1):85-101. [Medline].

Feldman M, Scharschmidt B, Zorab R, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 6th ed. Philadelphia, PA: WB Saunders; 1998.

Garcia-Pagan JC, Bosch J. Medical treatment of portal high blood pressure. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec. 14(6):895-909. [Medline].

Garcia-Tsao G. Current control of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001 Feb. 120(3):726-48. [Medline].

Goh SH, Tan WP, Lee SW. Clinical predictors of bleeding esophageal varices in the ED. Am J Emerg Med. 2005 Jul. 23(4):531-5. [Medline].

Henderson JM. Surgical remedy of portal hypertension. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec. 14(6):911-25. [Medline].

Krige JE, Beckingham IJ. ABC of sicknesses of liver, pancreas, and biliary gadget. Portal hypertension-1: varices. BMJ. 2001 Feb 10. 322(7282):348-51. [Medline].

Krige JE, Shaw JM, Bornman PC. The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg. 2005. 29:966-73. [Medline].

Lowe RC, Grace ND. Pharmacologic therapy for portal high blood pressure. Curr Gastroenterol Rep. 2001 Feb. 3(1):24-9. [Medline].

Merkel C, Zoli M, Siringo S. Prognostic signs of possibility for first variceal bleeding in cirrhosis: a multicenter learn about in 711 sufferers to validate and fortify the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol. 2000 Oct. 95(10):2915-20. [Medline].

Pruvot FR, Quandalle P, Paris JC. [What's left for surgical remedy of portal high blood pressure in cirrhosis patients?]. Gastroenterol Clin Biol. 2003 Nov. 27(11):1013-20. [Medline].

Russo MW, Brown RS Jr. Endoscopic treatment of patients with portal high blood pressure. Gastrointest Endosc Clin N Am. 2001 Jan. 11(1):1-14. [Medline].

Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural historical past of gastric varices: a long-term follow-up learn about in 568 portal hypertension sufferers. Hepatology. 1992 Dec. 16(6):1343-9. [Medline].

Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.

Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary System. tenth ed. Oxford, UK: Wiley-Blackwell; 1997.

Soares-Weiser K, Brezis M, Tur-Kaspa R. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized managed trials. Scand J Gastroenterol. 2003 Feb. 38(2):193-200. [Medline].

Sterling RK, Sanyal AJ. Are TIPS tops within the treatment of portal high blood pressure? A evaluate on the use and misuse of transjugular intrahepatic portosystemic shunts. Can J Gastroenterol. 2000 Nov. 14 Suppl D:122D-128D. [Medline].

Wongcharatrawee S, Groszmann RJ. Diagnosing portal high blood pressure. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec. 14(6):881-94. [Medline].